ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,959, issued on May 20, was assigned to 23andMe Inc. (Sunnyvale, Calif.).
"Method of treating asthma with anti-IL1RAP antibodies" was invented by Davide Foletti (Menlo Park, Calif.), Erik Karrer (Los Altos, Calif.), Germaine Fuh-Kelly (Pacifica, Calif.), Kristie Ibarra (San Jose, Calif.), Quan Zheng (Fremont, Calif.), Yao-ming Huang (San Mateo, Calif.), Lindsay Deis (San Bruno, Calif.), Christine Wolak (Burlingame, Calif.) and Dominic Samuel Berns (Redwood City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to human inter...